Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease
- PMID: 1645667
- DOI: 10.1007/BF02093715
Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease
Abstract
Twenty-six infants and children with congenital heart disease (CHD) undergoing cardiac surgery were investigated for alterations in myocardial beta-adrenoceptor density. The patients were divided into three groups according to type and severity of CHD: group I consisted of 6 patients with acyanotic shunt lesions of moderate severity; group II comprised 13 children with severe acyanotic shunt and valve lesions and group III included 7 children with cyanotic CHD. The myocardial beta-adrenoceptor density was determined using (-)3-[125I]Iodocyanopindolol [( 125I]ICYP) and was reduced by approximately 50% in severe acyanotic CHD (33.6 fmol/mg protein) and cyanotic CHD (35.3 fmol/mg protein) in comparison with the group with less severe acyanotic shunt defects (64.4 fmol/mg protein). The affinity dissociation constant (Kd.ICYP) did not differ statistically between the groups. The proportion of beta 1- and beta 2-subpopulations was evaluated by ICI 118,551-[125I]ICYP competition studies. In group II (61.5%) and group III (69.1%) significant lower portions of beta 1-adrenoceptors were found compared with group I (78.2%). This shift of subpopulations was due to a decreased beta 1-receptor density while beta 2-receptor density was unchanged in all groups. While the plasma noradrenaline levels of group I were similar to those of a control group of 13 healthy children, respective values of group II and III were significantly elevated. A significant negative correlation was found between plasma noradrenaline levels and myocardial beta-adrenoceptor density. It is concluded that exposure of these receptors to increased circulating catecholamines, due to an enhanced sympathetic tone, leads to a reduction of their density.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Beta-adrenoceptor density on mononuclear leukocytes and right atrial myocardium in infants and children with congenital heart disease.Klin Wochenschr. 1991 Dec 11;69(20):910-6. doi: 10.1007/BF01798537. Klin Wochenschr. 1991. PMID: 1665527
-
Distribution of myocardial beta-adrenoceptor subtypes and coupling to the adenylate cyclase in children with congenital heart disease and implications for treatment.J Clin Pharmacol. 1993 Jul;33(7):588-95. doi: 10.1002/j.1552-4604.1993.tb04709.x. J Clin Pharmacol. 1993. PMID: 8396157
-
Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.Cardiovasc Res. 1991 Sep;25(9):764-73. doi: 10.1093/cvr/25.9.764. Cardiovasc Res. 1991. PMID: 1666020
-
Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.Naunyn Schmiedebergs Arch Pharmacol. 1995 Apr;351(4):398-407. doi: 10.1007/BF00169081. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 7630430
-
COVID-19 in Cyanotic Congenital Heart Disease.Can J Infect Dis Med Microbiol. 2023 Apr 18;2023:5561159. doi: 10.1155/2023/5561159. eCollection 2023. Can J Infect Dis Med Microbiol. 2023. PMID: 37114013 Free PMC article. Review.
Cited by
-
Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure.Ital J Pediatr. 2012 Sep 12;38:41. doi: 10.1186/1824-7288-38-41. Ital J Pediatr. 2012. PMID: 22971785 Free PMC article. Review.
-
The myocardial profile of the cytosolic isozymes of creatine kinase is apparently not related to cyanosis in congenital heart disease.Mol Med. 1999 Feb;5(2):110-6. Mol Med. 1999. PMID: 10203576 Free PMC article.
-
Role of β-blocker therapy in pediatric heart failure.Ped Health. 2010;4(1):45-58. doi: 10.2217/phe.09.65. Ped Health. 2010. PMID: 21799703 Free PMC article.
-
Should beta-blockers be used for the treatment of pediatric patients with chronic heart failure?Paediatr Drugs. 2002;4(12):771-8. doi: 10.2165/00128072-200204120-00001. Paediatr Drugs. 2002. PMID: 12431129 Review.
-
Maximising the clinical use of exercise gaseous exchange testing in children with repaired cyanotic congenital heart defects: the development of an appropriate test strategy.Sports Med. 2000 Apr;29(4):229-44. doi: 10.2165/00007256-200029040-00002. Sports Med. 2000. PMID: 10783899 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical